Report on the St Petersburg International Forum on Pharmacy
16 May 2012
The IPhEB International Forum on pharmacy, medical industry
and biotechnology was successfully held in St Petersburg last month,
having gathered over 1,000 participants: heads of federal and regional
authorities defining the industry development policy, the largest higher
educational institutions and research centres of the country, as well as
companies from 18 regions of Russia and 15 countries.
The IPhEB 2012 Forum became one of the largest Russian events in
the scientific, technical and innovations sphere. The event was
mainly focused on elaboration of effective solutions for rapid
development of Russian pharmacy and medicine, creation, production
and introduction of innovative, high quality medications into
clinical practice in order to promote realization of state and
private initiatives for development of this extremely important
The Forum, held with active support and participation of the
Russian Ministry of Industry and Trade, St. Petersburg Government,
has gathered heads of executive authorities of all levels, rectors
of the largest domestic higher educational institutions and research
centers, top managers and experts of pharmacy companies, including
MSD, Novartis, Novo-Nordisk, Stada, Philips, AstraZeneca and others.
Medical radiology was the topic of the first day. A separate
conference was devoted to this subject. The conference plenary
session Medical radiology in Russia: trends and development
prospects — was chaired by Daria Ryzhkova, Deputy director for
educational activities of the Russian Scientific Center of Radiology
and Surgical Technology of the Federal Agency of hi-tech medical
aid. Creation of radiological cluster in Gatchina in 2015 became one
of the main focuses of attention at the discussions.
Arkady Stolpner, Board Chairman of Treatment and Diagnosi
Berezin’ Group, assesses the project opportunities quite
optimistically: I think, we will see the results within several
years. According to his words, it will take from five to seven
years. The most important task of the cluster is to develop staff
Elena Diesendorf, Head of the nuclear physics division at
Philips, presented in the topical session of the first day: Ways to
improve medical radiology in Russia — Localized recovery vs.
systematic development? She said that preparation of experts in
radiology is one of the most important spheres of healthcare
development in Russia.
Philips understands this and is currently running a project
jointly with Rosatom state corporation with the aim of creating an
enterprise for equipment production, discussing the opportunities to
participate in staff training in cooperation with the leading higher
educational institutions – National Research Nuclear University
MEPHI, Federal Medical Biophysical Center named after AI Burnazyan
and others. "We propose to strengthen material and technical base
for training specialists, sponsor their training courses in foreign
clinics, equip training classes, providing them with working
stations that will be modernised regularly. We are ready to invest
our own money into this process,” Elena Diesendorf informed.
The Forum business programme consisted of 13 topical sessions and
master classes on innovative development of pharmaceutical and
The plenary session National priorities in pharmaceutical
industry development, held on the second day of the Forum, was
opened by Georgy Poltavchenko, St. Petersburg Governor: “I am glad
to welcome the participants of the International Forum which is the
best site to discuss the issues of domestic pharmacy industry
development. This site creates favourable conditions for a dialogue
between pharmacists, business and authorities’. Georgy Poltavchenko
stressed that pharmacy is not only about business, but also about
work for the sake of human well-being.
Sergey Tsyb, Director of department for chemical and
technological complex and bio-engineering technologies of the
Ministry of Industry and Trade of the Russian Federation, in his
speech summed up the intermediate results of implementing the
federal target programme.
Development Strategy for Pharmaceutical and medical industry of
the Russian Federation for the period until 2020 and further
outlook’ as one of the most effective tools for complex industry
“St. Petersburg is demonstrating significant rates in terms of
innovative development of pharmacy and medical industry. Attractive
investment conditions have been created in the region. The city
itself — our northern capital — traditionally possesses the most
important resource for such a science-intensive industry as
medicine, namely it has human capital.
"Much has been done and is still being done for the successful
formation of one of the first innovative medical and pharmaceutical
clusters in Russia, which presupposes the increase in shares of
domestic pharmacy products, improvement of their competitiveness and
export opportunities. Thus, the region has all the prerequisites for
successful implementation of projects designed to create
pharmaceutical enterprises as well as research and development
centres within the framework of the PHARMA 2020 strategy”, Sergey
During a panel discussion on Optimisation of pricing strategy for
vital and essential medicines: search for effective tools for
sustainable development of the Russian pharmaceutical market, Dmitry
Ter-Stepanov, Head of Department for Competition Development,
Ministry for Economic, Development of the Russian Federation,
delivered a speech.
He informed that an inter-institutional group has been created
which is intended to elaborate price calculation method for new
medications under supervision of Deputy Minister Mikhail Oseevsky.
He said that current methods have become outdated and if we keep
using them, it may result in erosion of the whole medications groups
from the market, mainly the cheap ones, and the fact that the
manufacturer has no opportunity to re-register the price leads to
the polymorphism in drugs (even the smallest change in the name of
pharmaceuticals by adding another definition or a slight replacement
of the preparation components allows to register a new price).
The round table Promotion of R&D in the sphere of pharmacy and
biotechnology attracted special attention of the participants.
Moderator Vitaly Prutskiy, Head of R&D Information in Russia and
Eastern Europe, Head of Centre for bio-informatics and predictive
medicine in St. Petersburg, set an active tempo to the discussion,
having told how quickly — "it took AstraZeneca less than a year” —
the company managed to open a Center in St. Petersburg, which will
solve no only regional tasks but also will serve the whole world
using local resources. Participants of this round table focused
their attention on the opportunities and ambitions of Russian R&D
Alexander Garabadiu, Vice-Rector for research of St. Petersburg
Technological Institute, told about the experience of this
university in creating a modern laboratory designed to develop the
latest pharmaceuticals, provoking the same wave of optimism.
The laboratory is headed by Gennaro Melino, a famous Professor of
Molecular Biology, University of Rome. According to the agreement,
he has to spend four months a year in St. Petersburg, whereas
university students will be training for 5-6 months not only in
Italy, but also in England, Belgium, Germany and France. 140 million
rubles have been allotted to the project, most of this sum will be
spent to purchase modern equipment.
At the topical session International and regional cooperation in
the field of pharmacy and biotechnology, held on the second day of
the Forum, Zakhar Golant, Deputy Chairman of Committee for Economic
Development, Industrial Policy and Trade of St. Petersburg
Government, emphasized that the improvement of international
cooperation is necessary to develop the whole region, therefore the
Northern capital attaches great importance to the high quality
meetings and events industry.
Yury Sukhanov, Executive Director at the Association of Experts
in Biomedical technologies, cell technologies and regenerative
medicine, non-profit partnership ACTREMED, moderator of the session
Tools to support pharmaceutical and medical biotechnologies in
Russia. Outlooks for further development within the frameworks of
World Trade Organisation and Customs Union, being one of the
developers of the Law about Circulation of Biomedical Cell Products
notes that the 'legal terrain of biomedicine is not plowed and sown.
We have to be ready for significant changes in our market. It
concerns not only new pharmaceuticals, but also cooperation with
neighbouring countries', Yury Sukhanov emphasized.
It is for the first time that an IPhEB award in the sphere of
pharmacy and biotechnology was established with the aim to promote
development of the latest achievements in the sphere of
pharmaceutical, biotechnological and medical technologies. The
awarding ceremony and congratulations to the laureates took place
during gala reception on behalf of Georgy Poltavchenko, St.
Petersburg Governor on the occasion of the Forum Opening.
BIOCAD CJSC with its product Genferone Light Spray became the
winner in Product of the year nomination. Dmitry Morozov, Chairman
of the Board of Directors received the award. The nomination for
Business project of the year was awarded to the Center of protone
radiation therapy of the Center of nuclear medicine at the
International Institute of Biologic Systems named after S.M. Berezin.
The award was handed to Georgy Andreev, Chief Medical Physicist
of the company. The center implements modern methods of nuclear
medicine in clinical treatment practice, prolongs lives of
oncological patients as well. IPhEB Science, a special personal
award was honoured to Elena Shpakova — a second year graduate
student of RAS Institue of High-Molecular Compounds, for the best
work in the 'Chemical synthesis of biologically active substances’
For three working days of Business Matchmaking Center — a
communication site designed to establish new business and
partnership contacts — over 70 meetings were registered. The most
significant negotiations were: a meeting of representative of India
Ministry of pharmaceutical industry, the administration of the UBM
company (Great Britain) and Zakhar Golant, Deputy Chairman of
Committee for Economic Development, Industrial Policy and Trade, as
well as the meeting of FinnMedi company representatives with
Alexander Iova, Head of the Chair of Neurology and Neurosurgery at
the Medical Academy of Post-Graduate Education. The Business
Matchmaking Center became the major link between the Forum
participants and the exhibitors.
Another novelty of the Forum is the Exhibition of Medical
Pharmaceutical and Laboratory Equipment within the frameworks of
IPhEB Forum, representing the latest achievements, products and
services in the sphere of medical, pharmaceutical and
biotechnological industry. The exhibition was participated by the
largest Russian and foreign companies, including PHARMEXCIL (India),
Favea, Khimexpert, Sartorius IRC and others. A separate exposition
was formed by the companies, members of St. Petersburg
pharmaceutical and medical industry cluster - Novartis, MSD
Pharmaceuticals, Polysan, Samson-Med, Geropharm, LDC MIBS (Treatment
and Diagnostics Center of International Institute for Biological
systems) and NP Medical and ‘Pharmaceutical Projects. XXI century’.
A specialised tour took place within the frameworks of the
business programme - the IPhEB Forum participants visited a new
Federal Service on Surveillance in Healthcare and Social Development
of the Russian Federation for medicines quality control. It is
located in the four-storey building and occupies total area of 2,700
sq.m. The participants of this tour observed organisational
department, analytical, microbiological and pharmacological
laboratories, where 48 high-grade experts work. “You will not find
such a laboratory anywhere in the city. Unique people work here”,
Elena Telnova, acting as head of Roszdravnadzor, assures, “there are
only three laboratories of such a high level in Russia: in Gudermes,
Rostov-on-Don and Krasnoyarsk”. The plans include opening of
laboratories in Moscow and other cities. Within the nearest time, a
mobile express-laboratory on the basis of St. Petersburg laboratory
complex for medicines quality control will start working directly on
the inspection facility: pharmacies, drugstores, hospitals, clinics.
On the whole, as participants of the business programme and
exhibition exposition noted, the IPhEB Forum was held successfully.
Tatiana Mamaeva, Head of Regulatory Department, National Center of
Expertise for Phramaceutical Products of the Republic of Kazakhstan,
“I came from Kazakhstan to visit the Forum for the first time. I
have great impressions from organisation, discussions and topics. It
is undoubtedly an interesting and necessary event. The most
currently important topics of the modern pharmaceutical industry,
exciting for the specialists of all countries were discussed here.
It is a real platform for a dialogue. I wish I could visit all the
Robert Rosen, Director General of Selecta (RUS) Company, Bind
'It was a very interesting Forum. Such an event
contributes a lot to the future development of science. The Forum
lets us understand and find one's niche, find research and
administrative resources. The Forum provides all the opportunities
for future successful work. Success comes with clear purposes'.
Martin Schloh, Advisory in the sphere of pharmacy and
biotechnology at PricewaterhouseCoopers:
"I would like to thank
all event participants and organisers. Special thanks to the Forum
interpreters. I saw energy and light in the participants’ eyes'.
Sergey Smirnov, Board Chairman of Novo Nordisk LLC:
Petersburg International Forum IPhEB 'Pharmacy. Medicine.
Biotechnology’ left a very favourable impression by its scale,
organisation level, number of participants and topics under
discussion. I learned a lot of useful information. A wonderful panel
discussion has just finished, where I made a report. And yesterday a
plenary session took place, where Georgy Poltavchenko, St.
Petersburg Governor, Sergey Tsyb, Director of Department for
chemical and technological complex and bio-engineering technologies
of the Ministry of Industry and Trade of the Russian Federation,
Elena Telnova, Deputy Head of Federal Service for Supervision of
Healthcare and Social Development took part. Participation of such
high officials also proves the Forum significance for the Russian
pharmacy and biotechnology”.
In 2013 the IPhEB Forum will take place on April 22 to 24 in St.
Petersburg. For more information on the coming event, please visit
the official web-site www.ipheb.ru